HUTCHMED (China) Ltd - SPONSORED ADS (HCM) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / SPONSORED ADS
Symbol
HCM on Nasdaq
Price per share
$13.33
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,761,615
Total reported value
$90,656,720
% of total 13F portfolios
0%
Share change
-298,165
Value change
-$4,321,944
Number of holders
55
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 55 institutional investors reported holding 5,761,615 shares of HUTCHMED (China) Ltd - SPONSORED ADS (HCM).

Institutional Holders of HUTCHMED (China) Ltd - SPONSORED ADS (HCM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 8,008 $106,747 -$586,745 $13.33 2
2025 Q3 5,761,615 $90,656,720 -$4,321,944 $15.75 55
2025 Q2 6,069,514 $91,405,464 -$7,761,223 $15.05 61
2025 Q1 6,581,058 $99,610,173 -$4,194,039 $15.04 61
2024 Q4 6,880,160 $99,039,802 -$6,249,022 $14.41 67
2024 Q3 7,276,114 $141,021,542 -$25,941,942 $19.53 65
2024 Q2 8,759,839 $150,039,892 -$99,603,879 $17.12 65
2024 Q1 14,514,460 $243,760,794 -$19,297,600 $16.80 70
2023 Q4 15,414,966 $278,719,091 -$136,910,502 $18.11 70
2023 Q3 23,025,870 $390,557,590 -$12,626,370 $16.94 64
2023 Q2 22,159,294 $265,829,551 -$2,714,358 $12.00 66
2023 Q1 24,610,925 $320,287,353 -$44,644,923 $13.02 68
2022 Q4 27,666,839 $412,794,938 -$115,743,595 $14.78 83
2022 Q3 38,301,053 $340,978,537 -$92,496,312 $8.86 97
2022 Q2 48,542,862 $615,075,909 -$74,295,169 $12.64 102
2022 Q1 50,890,898 $967,381,043 -$75,047,088 $18.92 120
2021 Q4 50,577,471 $1,774,121,316 -$28,521,429 $35.08 139
2021 Q3 50,801,723 $1,861,258,393 +$194,929,792 $36.61 136
2021 Q2 46,277,274 $1,809,855,112 -$7,759,763 $39.27 139
2021 Q1 46,550,926 $1,313,904,221 +$24,105,667 $28.25 124
2020 Q4 43,381,761 $1,389,192,948 +$35,267,512 $32.02 121
2020 Q3 45,664,466 $1,470,578,401 +$118,192,106 $32.30 119
2020 Q2 42,019,321 $1,160,335,288 +$59,421,470 $27.58 113
2020 Q1 41,121,137 $736,341,963 +$66,188,129 $17.85 102
2019 Q4 37,347,832 $936,048,125 -$21,719,138 $25.07 108
2019 Q3 35,607,632 $635,933,823 +$24,566,858 $17.84 103
2019 Q2 34,688,130 $765,026,284 +$288,403,209 $22.00 117
2019 Q1 27,324,974 $835,424,052 +$104,865,206 $30.58 91
2018 Q4 22,325,837 $515,467,447 +$131,882,362 $23.09 75
2018 Q3 16,033,749 $516,032,578 +$15,513,941 $32.19 39
2018 Q2 15,569,732 $469,957,523 +$69,690,193 $30.14 38
2018 Q1 13,265,455 $392,128,628 +$86,407,841 $29.56 38
2017 Q4 10,221,673 $402,598,000 +$134,628,229 $39.42 37
2017 Q3 5,301,327 $144,540,000 +$10,760,153 $27.27 24
2017 Q2 4,907,304 $114,381,000 +$1,166,567 $23.31 17
2017 Q1 4,896,368 $98,277,000 -$3,203,293 $19.95 17
2016 Q4 5,116,634 $69,432,000 +$11,774,498 $13.57 13
2016 Q3 4,295,035 $51,198,000 +$6,693,715 $11.90 16
2016 Q2 3,746,500 $49,265,000 -$977,907 $13.15 20
2016 Q1 3,788,174 $50,002,000 +$49,278,000 $13.20 23